Vancomycin Resistant Enterococci Infection: Clinical Trials

4 trials for Vancomycin Resistant Enterococci Infection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 completed, 1 unknown. 2 Not applicable, 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 1, Recruiting 1
Phase 21Recruiting 1
Phase 31Recruiting 1

Follow Vancomycin Resistant Enterococci Infection: new trials by email Literature Review of Vancomycin Resistant Enterococci Infection trials Research Report on Vancomycin Resistant Enterococci Infection

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Enteral Vancomycin as Primary Prophylaxis Against Clostridioides Difficile Infection in Critically Ill Patients
Vancomycin 125mg, Placebo - Clostridium Difficile Infection, Vancomycin Resistant Enterococci Infection
Phase 2 / Phase 3RecruitingRiverside University Health System Medical Center1762024-10-212025-11-10
Dynamics of Colonization and Infection by Multidrug-Resistant Pathogens in Immunocompromised and Critically Ill Patients
Antimicrobial Drug Resistance, Antibiotic Resistant Infection
UnknownThe Methodist Hospital Research Institute10002020-12-082024-02-14
Safety and Efficacy of Fecal Microbiota Transplantation
Fecal Microbiota Transplantation - Crohn Disease, Ulcerative Colitis
Not applicableRecruitingChinese University of Hong Kong4502019-07-152024-08-22
Hospital Design and Risk of Nosocomial Infections: A Prospective Controlled Trial
Admission to a novel hospital ward - Vancomycin Resistant Enterococci Infection, Clostridium Difficile Infection
Not applicableCompletedUniversity of Calgary15142007-06-012018-10-23

Narrower conditions

Clostridium Infections (3)  ·  Alcoholism (1)  ·  Alopecia (1)  ·  Arthritis, Psoriatic (1)  ·  Autistic Disorder (1)  ·  Celiac Disease (1)  ·  Colitis, Ulcerative (1)  ·  Constipation (1)  ·  Crohn Disease (1)  ·  Cross Infection (1)  ·  Diabetes Mellitus (1)  ·  Enterocolitis, Pseudomembranous (1)  ·  Graft vs Host Disease (1)  ·  Hepatic Encephalopathy (1)  ·  Hypersensitivity (1)

Broader conditions

Bacterial Infections (3)  ·  Bacterial Infections and Mycoses (3)  ·  Gram-Positive Bacterial Infections (3)  ·  Infections (3)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Alcohol-Related Disorders (1)  ·  Arthritis (1)  ·  Autism Spectrum Disorder (1)  ·  Autoimmune Diseases (1)  ·  Autoimmune Diseases of the Nervous System (1)  ·  Blood Coagulation Disorders (1)  ·  Blood Platelet Disorders (1)  ·  Body Weight (1)  ·  Bone Diseases (1)

Interventions

Fecal Microbiota Transplantation (1)  ·  Vancomycin (1)

Sponsors

Chinese University of Hong Kong (1)  ·  Riverside University Health System Medical Center (1)  ·  The Methodist Hospital Research Institute (1)  ·  University of Calgary (1)

Countries

United States (2)  ·  Canada (1)  ·  Hong Kong (1)

Top investigators

Cesar A Arias, MD, PhD, Msc (1)  ·  Donna Holton, MD (1)  ·  Elizabeth A Henderson, PhD (1)  ·  Jean Wallace, PhD (1)  ·  John M Conly, MD (1)  ·  Manuel Mah, MD (1)  ·  Peter Faris, PhD (1)  ·  Siew Ng (1)  ·  William A Ghali, MD (1)

NIH funding

P01AI152999 (1)